Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Matthew Ellis

Concepts (510)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
107
2025
2418
10.930
Why?
Antineoplastic Agents, Hormonal
27
2021
196
5.700
Why?
Receptors, Estrogen
38
2025
406
4.920
Why?
Aromatase Inhibitors
21
2022
81
4.620
Why?
Neoadjuvant Therapy
23
2024
475
2.850
Why?
Drug Resistance, Neoplasm
20
2024
893
2.830
Why?
Nitriles
19
2024
212
2.740
Why?
Triazoles
19
2024
190
2.690
Why?
Estrogen Receptor alpha
11
2023
154
2.650
Why?
Biomarkers, Tumor
27
2024
1339
2.630
Why?
Antineoplastic Combined Chemotherapy Protocols
24
2024
1998
2.340
Why?
Triple Negative Breast Neoplasms
9
2024
220
2.140
Why?
Cyclin-Dependent Kinase 4
8
2025
52
2.070
Why?
Cyclin-Dependent Kinase 6
7
2025
49
2.020
Why?
Proteogenomics
7
2022
12
2.000
Why?
Mutation
28
2024
4093
1.910
Why?
Antineoplastic Agents
18
2024
2219
1.630
Why?
Ki-67 Antigen
10
2024
120
1.450
Why?
Neoplasms, Hormone-Dependent
5
2016
33
1.350
Why?
Gene Expression Profiling
17
2021
1792
1.240
Why?
Proteomics
19
2022
1203
1.160
Why?
Protein Kinase Inhibitors
10
2025
983
1.120
Why?
Aromatase
3
2016
37
1.110
Why?
Quinolines
5
2022
191
1.060
Why?
Female
120
2025
79499
1.000
Why?
Class I Phosphatidylinositol 3-Kinases
6
2018
111
0.970
Why?
Genome, Human
5
2016
431
0.960
Why?
Opioid-Related Disorders
6
2025
634
0.960
Why?
Chemotherapy, Adjuvant
15
2020
429
0.940
Why?
Carcinoma, Ductal, Breast
3
2015
92
0.930
Why?
Xenograft Model Antitumor Assays
17
2025
930
0.900
Why?
Tamoxifen
10
2019
193
0.890
Why?
Humans
142
2025
146342
0.880
Why?
Prognosis
22
2022
4351
0.840
Why?
Neoplasm Recurrence, Local
13
2022
1160
0.830
Why?
Trastuzumab
5
2020
119
0.830
Why?
Postmenopause
8
2024
394
0.820
Why?
Estradiol
7
2016
517
0.810
Why?
Piperazines
6
2025
368
0.800
Why?
Neoplasm Staging
17
2019
1488
0.730
Why?
Substance Abuse, Intravenous
1
2024
131
0.710
Why?
Pyridines
6
2025
610
0.700
Why?
Disease-Free Survival
13
2019
778
0.680
Why?
Circulating Tumor DNA
2
2022
50
0.670
Why?
Proto-Oncogene Proteins c-akt
3
2017
441
0.610
Why?
Molecular Sequence Annotation
4
2016
110
0.610
Why?
Oncogene Proteins, Fusion
1
2021
213
0.600
Why?
Kaplan-Meier Estimate
11
2018
970
0.590
Why?
Estrogens
3
2011
364
0.590
Why?
Heterografts
7
2021
143
0.570
Why?
Cell Line, Tumor
16
2025
3545
0.570
Why?
MutL Proteins
2
2021
3
0.570
Why?
Gene Expression Regulation, Neoplastic
15
2021
1432
0.570
Why?
Genomics
10
2022
853
0.560
Why?
Receptors, Progesterone
9
2018
242
0.560
Why?
Gene Fusion
1
2018
31
0.550
Why?
Phosphatidylinositol 3-Kinases
5
2018
384
0.530
Why?
Middle Aged
48
2025
36619
0.530
Why?
HIV Infections
2
2024
3215
0.520
Why?
Checkpoint Kinase 2
1
2017
27
0.520
Why?
Aged
43
2024
26432
0.520
Why?
Treatment Outcome
20
2021
11821
0.510
Why?
Transcriptome
9
2021
1068
0.500
Why?
Cell Proliferation
9
2025
2502
0.500
Why?
Gene Amplification
6
2017
116
0.490
Why?
Androstadienes
6
2017
77
0.490
Why?
Neoplasms
10
2022
2954
0.490
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2017
59
0.480
Why?
Mammary Neoplasms, Experimental
2
2015
61
0.480
Why?
Proteome
7
2020
520
0.470
Why?
Neoplasm Metastasis
6
2018
693
0.460
Why?
Mice
27
2025
18297
0.430
Why?
Selective Estrogen Receptor Modulators
3
2016
33
0.420
Why?
Animals
34
2025
38107
0.420
Why?
Carcinoma, Lobular
1
2014
59
0.410
Why?
Signal Transduction
17
2021
5246
0.400
Why?
Apoptosis
6
2024
2439
0.400
Why?
Survival Analysis
8
2019
1378
0.390
Why?
Adult
39
2025
41087
0.390
Why?
Pharmaceutical Services, Online
1
2012
1
0.380
Why?
Endocrine System
2
2010
23
0.380
Why?
Proportional Hazards Models
6
2019
1331
0.380
Why?
Neurofibromin 1
2
2025
26
0.360
Why?
Sequence Analysis, DNA
4
2017
771
0.360
Why?
Carcinoma
2
2020
225
0.360
Why?
MCF-7 Cells
6
2021
133
0.350
Why?
Ergocalciferols
1
2011
15
0.340
Why?
E2F Transcription Factors
1
2011
65
0.340
Why?
Prescription Drugs
1
2012
110
0.330
Why?
Bone Density Conservation Agents
1
2011
83
0.320
Why?
RNA, Messenger
3
2021
2791
0.320
Why?
Combined Modality Therapy
5
2017
1271
0.310
Why?
Predictive Value of Tests
5
2017
2113
0.310
Why?
Musculoskeletal Diseases
1
2011
95
0.300
Why?
Randomized Controlled Trials as Topic
7
2025
1763
0.300
Why?
Mice, Nude
4
2021
668
0.290
Why?
Colonic Neoplasms
3
2019
259
0.290
Why?
Precision Medicine
1
2013
462
0.280
Why?
Mastectomy
4
2015
189
0.280
Why?
Antibodies, Monoclonal
3
2013
1512
0.280
Why?
Genetic Predisposition to Disease
3
2015
2488
0.280
Why?
Protein Kinases
4
2020
311
0.270
Why?
Internet
1
2012
660
0.270
Why?
Heterocyclic Compounds, 3-Ring
3
2017
44
0.270
Why?
Survival Rate
5
2021
2092
0.270
Why?
Oxycodone
2
2025
53
0.260
Why?
Molecular Targeted Therapy
3
2020
447
0.260
Why?
Disease Models, Animal
8
2023
4580
0.250
Why?
Pregnancy Complications, Neoplastic
1
2007
64
0.240
Why?
Paclitaxel
4
2016
260
0.240
Why?
Immunohistochemistry
6
2021
1712
0.240
Why?
Antigens, Neoplasm
3
2020
271
0.240
Why?
Aged, 80 and over
14
2021
8391
0.240
Why?
Brain Neoplasms
1
2016
1325
0.240
Why?
Morpholines
2
2018
130
0.230
Why?
Aminopyridines
2
2018
128
0.230
Why?
Analgesics, Opioid
4
2025
1221
0.230
Why?
MAP Kinase Kinase Kinase 1
2
2018
19
0.230
Why?
MAP Kinase Kinase 4
2
2018
24
0.230
Why?
Carboplatin
2
2022
168
0.220
Why?
ROC Curve
2
2017
617
0.220
Why?
Delayed-Action Preparations
3
2025
192
0.210
Why?
Prescription Drug Misuse
1
2025
58
0.210
Why?
Homologous Recombination
1
2024
38
0.210
Why?
Phosphorylation
8
2021
1724
0.210
Why?
Neoplasm Transplantation
4
2017
238
0.200
Why?
Phosphoric Monoester Hydrolases
1
2004
59
0.200
Why?
Needle-Exchange Programs
1
2024
16
0.200
Why?
Healthcare Disparities
2
2025
733
0.200
Why?
Radiation Tolerance
1
2024
101
0.200
Why?
Naloxone
1
2025
139
0.200
Why?
Tramadol
1
2023
17
0.200
Why?
DNA Mutational Analysis
2
2016
410
0.200
Why?
TOR Serine-Threonine Kinases
2
2020
455
0.190
Why?
Risk Assessment
7
2016
3712
0.190
Why?
Clinical Decision-Making
2
2017
365
0.190
Why?
Harm Reduction
1
2024
49
0.190
Why?
Abscess
1
2024
77
0.190
Why?
Abuse-Deterrent Formulations
1
2023
3
0.190
Why?
Treatment Adherence and Compliance
1
2023
27
0.190
Why?
Drug Compounding
1
2024
106
0.190
Why?
Ovarian Neoplasms
3
2014
604
0.190
Why?
Clinical Trials as Topic
4
2012
1064
0.190
Why?
Peptides
4
2016
992
0.190
Why?
Risk Factors
8
2023
10921
0.190
Why?
X-ray Repair Cross Complementing Protein 1
1
2022
14
0.190
Why?
Mass Spectrometry
5
2018
729
0.190
Why?
Oligonucleotide Array Sequence Analysis
4
2016
752
0.190
Why?
Chemoradiotherapy
1
2024
238
0.190
Why?
Narcotic Antagonists
1
2025
210
0.180
Why?
Incidence
5
2023
2936
0.180
Why?
Computational Biology
4
2015
678
0.180
Why?
Purines
1
2023
188
0.180
Why?
Health Equity
1
2025
139
0.180
Why?
Transfection
2
2018
916
0.180
Why?
Tumor Suppressor Proteins
1
2004
315
0.180
Why?
In Situ Hybridization, Fluorescence
3
2009
334
0.180
Why?
Epithelial-Mesenchymal Transition
3
2020
219
0.170
Why?
Enzyme Inhibitors
1
2005
823
0.170
Why?
Alleles
2
2016
907
0.170
Why?
PTEN Phosphohydrolase
3
2015
166
0.170
Why?
Maximum Tolerated Dose
4
2016
217
0.170
Why?
Transplantation, Heterologous
4
2015
165
0.170
Why?
Protein-Tyrosine Kinases
1
2024
429
0.170
Why?
DNA Mismatch Repair
1
2021
54
0.160
Why?
Transcription Factor AP-1
1
2020
76
0.160
Why?
Health Knowledge, Attitudes, Practice
2
2025
1408
0.160
Why?
Antibodies, Monoclonal, Humanized
4
2015
992
0.160
Why?
Biopsy, Large-Core Needle
1
2020
15
0.150
Why?
Basal Ganglia Diseases
1
2020
10
0.150
Why?
Tumor Cells, Cultured
1
2021
882
0.150
Why?
Calcium-Binding Proteins
2
2018
221
0.150
Why?
Buprenorphine
1
2023
197
0.150
Why?
Mastectomy, Segmental
3
2015
107
0.150
Why?
Carrier Proteins
1
2023
728
0.150
Why?
Cohort Studies
3
2020
6077
0.140
Why?
Genetic Variation
2
2015
996
0.140
Why?
Receptor Protein-Tyrosine Kinases
1
2020
227
0.140
Why?
Discoidin Domain Receptor 1
1
2018
3
0.140
Why?
Carcinogenesis
1
2020
226
0.140
Why?
Class Ia Phosphatidylinositol 3-Kinase
1
2018
8
0.140
Why?
tau Proteins
1
2020
111
0.140
Why?
Influenza Vaccines
1
2023
544
0.140
Why?
DNA Repair
3
2020
255
0.140
Why?
DNA Glycosylases
1
2018
10
0.140
Why?
Renal Insufficiency, Chronic
1
2025
640
0.140
Why?
Kidney Transplantation
1
2025
735
0.140
Why?
Antineoplastic Agents, Immunological
1
2021
200
0.140
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2018
8
0.140
Why?
Endonucleases
1
2018
35
0.140
Why?
Imidazoles
2
2010
245
0.140
Why?
NIMA-Related Kinases
1
2018
9
0.140
Why?
Transcriptional Activation
2
2018
369
0.130
Why?
Thymidine Kinase
1
2017
14
0.130
Why?
Time Factors
5
2016
7109
0.130
Why?
Centrifugation, Density Gradient
1
2017
37
0.130
Why?
Phosphoproteins
3
2016
320
0.130
Why?
Drug Synergism
2
2016
354
0.130
Why?
Genomic Instability
2
2020
64
0.130
Why?
Neurodegenerative Diseases
1
2020
147
0.130
Why?
Down-Regulation
1
2020
614
0.130
Why?
Tandem Mass Spectrometry
6
2017
576
0.130
Why?
Endometrial Neoplasms
1
2020
205
0.130
Why?
Adenocarcinoma
2
2015
927
0.130
Why?
Reproducibility of Results
3
2017
3416
0.130
Why?
High-Throughput Nucleotide Sequencing
3
2017
539
0.130
Why?
Neoplasm Proteins
3
2017
444
0.130
Why?
Translocation, Genetic
2
2018
127
0.130
Why?
Mitotic Index
1
2017
24
0.130
Why?
RNA, Neoplasm
2
2014
76
0.120
Why?
Spiro Compounds
1
2016
18
0.120
Why?
Tumor Microenvironment
2
2020
747
0.120
Why?
Enzyme Activation
4
2017
759
0.120
Why?
Polymorphism, Single Nucleotide
5
2015
2240
0.120
Why?
Papillomavirus Infections
1
2021
345
0.120
Why?
Estrogen Receptor Antagonists
1
2016
4
0.120
Why?
Substance Abuse Treatment Centers
1
2016
48
0.120
Why?
Health Services Accessibility
1
2025
1107
0.120
Why?
Proto-Oncogene Proteins c-mdm2
1
2016
66
0.120
Why?
Proteolysis
1
2017
174
0.120
Why?
Disease Progression
3
2020
2867
0.120
Why?
Clone Cells
1
2016
259
0.120
Why?
Point Mutation
2
2014
232
0.120
Why?
SEER Program
2
2014
233
0.120
Why?
RNA Interference
3
2018
472
0.120
Why?
Double-Blind Method
3
2016
2070
0.110
Why?
United States
7
2025
16136
0.110
Why?
Genes, Neoplasm
1
2015
26
0.110
Why?
Tumor Suppressor Protein p53
2
2016
530
0.110
Why?
Retreatment
1
2015
79
0.110
Why?
Capecitabine
1
2015
56
0.110
Why?
Risk
2
2015
920
0.110
Why?
Exome
2
2017
233
0.110
Why?
Clinical Trials, Phase III as Topic
1
2015
116
0.110
Why?
RNA, Small Interfering
3
2018
633
0.110
Why?
Clinical Laboratory Techniques
1
2016
96
0.110
Why?
Epitopes
1
2017
479
0.110
Why?
Salvage Therapy
1
2016
166
0.110
Why?
Genotype
3
2015
1879
0.110
Why?
Adaptor Proteins, Signal Transducing
2
2018
429
0.110
Why?
Receptors, Cell Surface
1
2017
371
0.110
Why?
Vasomotor System
1
2014
47
0.110
Why?
Follow-Up Studies
4
2017
5439
0.110
Why?
Neoplastic Cells, Circulating
2
2018
81
0.100
Why?
Neoplasm Grading
4
2017
313
0.100
Why?
CD8-Positive T-Lymphocytes
2
2019
931
0.100
Why?
Receptor, ErbB-3
1
2014
48
0.100
Why?
Biomarkers
3
2017
4340
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2015
974
0.100
Why?
Multivariate Analysis
2
2015
1543
0.100
Why?
Neuregulin-1
1
2014
50
0.100
Why?
Cell Cycle
1
2017
595
0.100
Why?
Musculoskeletal System
1
2014
53
0.100
Why?
Specimen Handling
1
2016
178
0.100
Why?
Cell Cycle Proteins
1
2018
630
0.100
Why?
Pilot Projects
1
2020
1888
0.100
Why?
Cancer Survivors
1
2019
348
0.100
Why?
Clonal Evolution
1
2014
47
0.100
Why?
Neoplasm Invasiveness
4
2018
504
0.100
Why?
National Human Genome Research Institute (U.S.)
1
2013
1
0.100
Why?
Cold Ischemia
1
2014
39
0.100
Why?
Asphyxia Neonatorum
1
2013
20
0.100
Why?
Cell Cycle Checkpoints
3
2020
97
0.100
Why?
National Cancer Institute (U.S.)
1
2013
56
0.100
Why?
Genes, erbB-2
1
2013
32
0.100
Why?
Osteoporotic Fractures
1
2014
62
0.100
Why?
Neoplasms, Basal Cell
1
2013
4
0.100
Why?
Cell Adhesion Molecules
1
2014
180
0.100
Why?
Alternative Splicing
1
2015
253
0.100
Why?
Sequence Analysis, RNA
1
2015
441
0.100
Why?
Nerve Tissue Proteins
1
2017
597
0.090
Why?
Central Nervous System Diseases
1
2013
73
0.090
Why?
Rectal Neoplasms
1
2014
160
0.090
Why?
Bone Neoplasms
1
2015
272
0.090
Why?
Chromatography, Liquid
4
2017
453
0.090
Why?
Amino Acid Sequence
2
2015
2092
0.090
Why?
Protein Biosynthesis
1
2015
449
0.090
Why?
Sirolimus
3
2013
282
0.090
Why?
NIH 3T3 Cells
1
2012
147
0.090
Why?
Young Adult
9
2025
14330
0.090
Why?
Indoles
1
2016
511
0.090
Why?
Stroke Volume
1
2016
652
0.090
Why?
Ventricular Dysfunction, Left
1
2016
391
0.090
Why?
Lymph Nodes
1
2015
511
0.090
Why?
Ventricular Function, Left
1
2016
541
0.090
Why?
Pain
2
2023
790
0.090
Why?
Lymphatic Metastasis
2
2015
335
0.090
Why?
Sequence Homology, Amino Acid
1
2012
382
0.090
Why?
Hyperglycemia
1
2016
384
0.090
Why?
Gene Expression
2
2015
1463
0.090
Why?
Osteoporosis
1
2014
240
0.090
Why?
Bone Density
2
2014
494
0.080
Why?
Quinazolines
1
2012
267
0.080
Why?
Insulin-Like Growth Factor I
2
2013
320
0.080
Why?
Exons
1
2012
361
0.080
Why?
Poison Control Centers
2
2025
85
0.080
Why?
DNA-Binding Proteins
1
2018
1468
0.080
Why?
Case-Control Studies
1
2018
3647
0.080
Why?
Parathyroid Hormone
1
2011
118
0.080
Why?
Global Health
1
2013
403
0.080
Why?
Protein Structure, Tertiary
1
2012
834
0.080
Why?
Mice, Inbred NOD
3
2017
598
0.080
Why?
Dose-Response Relationship, Drug
3
2021
2022
0.080
Why?
Retinoblastoma Protein
2
2020
63
0.080
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2010
61
0.080
Why?
Genes, BRCA1
1
2010
45
0.080
Why?
Diphosphonates
1
2010
68
0.070
Why?
Carcinoma, Squamous Cell
1
2014
628
0.070
Why?
Head and Neck Neoplasms
1
2014
563
0.070
Why?
Cell Growth Processes
1
2009
47
0.070
Why?
Liver Neoplasms
1
2015
776
0.070
Why?
Male
12
2025
73396
0.070
Why?
Radiopharmaceuticals
1
2009
210
0.070
Why?
Missouri
2
2023
66
0.070
Why?
Fluorodeoxyglucose F18
1
2009
164
0.070
Why?
Age Factors
4
2019
3347
0.070
Why?
Molecular Sequence Data
1
2012
2838
0.070
Why?
Mice, SCID
2
2021
360
0.070
Why?
Cross-Sectional Studies
3
2025
5899
0.070
Why?
Neoplasms, Second Primary
1
2009
103
0.070
Why?
Vitamin D
1
2011
402
0.070
Why?
DNA Copy Number Variations
2
2022
192
0.070
Why?
Models, Molecular
1
2012
1574
0.060
Why?
Positron-Emission Tomography
1
2009
343
0.060
Why?
Health Planning Guidelines
1
2007
23
0.060
Why?
Prospective Studies
5
2019
8123
0.060
Why?
Trinidad and Tobago
2
2018
5
0.060
Why?
Gonadotropin-Releasing Hormone
1
2009
215
0.060
Why?
Perception
1
2010
373
0.060
Why?
Cyclophosphamide
2
2020
275
0.060
Why?
Cell Line
1
2012
2814
0.060
Why?
Gene Knockdown Techniques
2
2021
335
0.060
Why?
Microsatellite Repeats
2
2020
159
0.060
Why?
Genes, erbB-1
1
2006
21
0.060
Why?
Genome
2
2021
307
0.060
Why?
Body Mass Index
1
2015
2458
0.060
Why?
Leukemia, Myeloid, Acute
2
2014
702
0.060
Why?
Hypoglycemic Agents
1
2016
1412
0.060
Why?
Analysis of Variance
1
2008
1298
0.060
Why?
Forecasting
1
2007
388
0.060
Why?
Immunotherapy
2
2021
671
0.060
Why?
Quality of Life
2
2009
3200
0.060
Why?
Cyclin D1
1
2025
64
0.060
Why?
ErbB Receptors
2
2021
636
0.060
Why?
Transcription Factors
1
2013
1730
0.050
Why?
Calcium
1
2011
1181
0.050
Why?
Protein Processing, Post-Translational
2
2020
487
0.050
Why?
Algorithms
3
2019
1849
0.050
Why?
Phenotype
1
2013
3206
0.050
Why?
Endpoint Determination
1
2005
84
0.050
Why?
Rad51 Recombinase
1
2024
15
0.050
Why?
Pragmatic Clinical Trials as Topic
1
2025
135
0.050
Why?
Antibiotics, Antineoplastic
1
2005
141
0.050
Why?
Genes, Tumor Suppressor
1
2004
84
0.050
Why?
BRCA2 Protein
1
2024
69
0.050
Why?
BRCA1 Protein
1
2024
84
0.050
Why?
Comparative Effectiveness Research
1
2025
171
0.050
Why?
Pregnancy Outcome
1
2007
503
0.050
Why?
Base Sequence
1
2007
2123
0.050
Why?
Biopsy
1
2007
1075
0.050
Why?
Cost-Benefit Analysis
1
2006
640
0.050
Why?
Drug Administration Schedule
2
2016
790
0.050
Why?
Oxymorphone
1
2023
5
0.050
Why?
Health Care Costs
1
2006
423
0.050
Why?
Phenols
1
2023
106
0.050
Why?
Proteins
2
2021
1022
0.050
Why?
Cisplatin
1
2024
347
0.040
Why?
Recurrence
2
2015
1133
0.040
Why?
Staurosporine
2
2012
22
0.040
Why?
Brazil
1
2022
179
0.040
Why?
Nursing Homes
1
2023
171
0.040
Why?
MutL Protein Homolog 1
1
2021
11
0.040
Why?
Regression Analysis
2
2016
999
0.040
Why?
Databases, Factual
1
2007
1493
0.040
Why?
Radiotherapy
2
2015
209
0.040
Why?
APOBEC Deaminases
1
2020
6
0.040
Why?
Genes, cdc
1
2020
11
0.040
Why?
Camptothecin
2
2012
139
0.040
Why?
Drug Overdose
1
2025
377
0.040
Why?
Bridged-Ring Compounds
1
2020
31
0.040
Why?
Anthracyclines
1
2020
49
0.040
Why?
Patient-Centered Care
1
2025
553
0.040
Why?
Feedback, Physiological
1
2020
79
0.040
Why?
Taxoids
1
2020
115
0.040
Why?
Mutagenesis
1
2020
196
0.040
Why?
Time-to-Treatment
1
2022
257
0.040
Why?
Estrogen Antagonists
1
2019
37
0.040
Why?
Acetylation
1
2020
262
0.040
Why?
Microsatellite Instability
1
2019
57
0.040
Why?
Fluorouracil
1
2020
231
0.040
Why?
Methotrexate
1
2020
234
0.030
Why?
Premenopause
1
2019
130
0.030
Why?
Cell Hypoxia
1
2019
249
0.030
Why?
Goosecoid Protein
1
2018
2
0.030
Why?
Keratin-19
1
2018
4
0.030
Why?
Snail Family Transcription Factors
1
2018
18
0.030
Why?
Biological Mimicry
1
2017
2
0.030
Why?
Endosomal Sorting Complexes Required for Transport
1
2018
46
0.030
Why?
DNA Damage
1
2020
439
0.030
Why?
Cell Survival
1
2021
1105
0.030
Why?
Medicare
1
2023
920
0.030
Why?
Epitope Mapping
1
2017
61
0.030
Why?
RNA, Double-Stranded
1
2017
58
0.030
Why?
Glycolysis
1
2019
342
0.030
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2017
39
0.030
Why?
Stromal Cells
1
2017
123
0.030
Why?
Web Browser
1
2016
12
0.030
Why?
Forkhead Transcription Factors
1
2018
209
0.030
Why?
Protein Interaction Maps
1
2016
54
0.030
Why?
Electronic Health Records
1
2025
1210
0.030
Why?
Receptor-Interacting Protein Serine-Threonine Kinase 2
1
2016
5
0.030
Why?
p21-Activated Kinases
1
2016
13
0.030
Why?
Bone Marrow Cells
1
2018
328
0.030
Why?
Chromosomes, Human, Pair 5
1
2016
30
0.030
Why?
S-Phase Kinase-Associated Proteins
1
2016
19
0.030
Why?
T-Lymphocytes, Cytotoxic
1
2017
180
0.030
Why?
Focal Adhesion Kinase 1
1
2016
32
0.030
Why?
Antigen Presentation
1
2017
209
0.030
Why?
Cerebral Cortex
1
2020
485
0.030
Why?
Interferons
1
2017
186
0.030
Why?
Chromosome Deletion
1
2016
127
0.030
Why?
src-Family Kinases
1
2016
93
0.030
Why?
Chromosome Mapping
1
2016
508
0.030
Why?
Quality Control
1
2015
163
0.030
Why?
Quality Assurance, Health Care
1
2017
349
0.030
Why?
Molecular Weight
1
2015
295
0.030
Why?
Cyclin-Dependent Kinases
1
2016
121
0.030
Why?
Viruses
1
2017
165
0.030
Why?
Geography
1
2015
187
0.030
Why?
Molecular Typing
1
2014
21
0.030
Why?
Metabolic Networks and Pathways
1
2015
175
0.030
Why?
Metabolomics
1
2020
738
0.030
Why?
Pandemics
1
2023
1707
0.030
Why?
Observer Variation
1
2015
356
0.030
Why?
Neoplastic Processes
1
2014
5
0.030
Why?
Antibodies, Neoplasm
1
2014
34
0.030
Why?
Hepatocyte Nuclear Factor 4
1
2014
15
0.030
Why?
Chromosomes, Human, Pair 20
1
2014
17
0.030
Why?
Proto-Oncogene Proteins pp60(c-src)
1
2014
14
0.030
Why?
Databases, Genetic
1
2015
239
0.030
Why?
Mitochondrial Membrane Transport Proteins
1
2014
46
0.030
Why?
Drug Prescriptions
1
2016
314
0.030
Why?
Adolescent
4
2019
22557
0.030
Why?
Gene Regulatory Networks
1
2016
319
0.030
Why?
Pregnancy
1
2007
7230
0.030
Why?
T-Lymphocytes, Regulatory
1
2017
415
0.030
Why?
Repressor Proteins
1
2017
430
0.030
Why?
Receptors, G-Protein-Coupled
1
2016
233
0.030
Why?
Models, Biological
1
2021
1761
0.030
Why?
Cluster Analysis
1
2015
496
0.030
Why?
Hot Flashes
1
2014
92
0.030
Why?
Data Interpretation, Statistical
1
2015
368
0.030
Why?
CpG Islands
1
2014
175
0.030
Why?
Guidelines as Topic
1
2016
267
0.020
Why?
Research Personnel
1
2016
190
0.020
Why?
Infusions, Intravenous
1
2015
432
0.020
Why?
Mass Screening
1
2022
1307
0.020
Why?
Chromatography, High Pressure Liquid
1
2015
588
0.020
Why?
MicroRNAs
1
2020
699
0.020
Why?
Insulin-Like Growth Factor II
1
2013
24
0.020
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
32
0.020
Why?
Inhibitory Concentration 50
1
2013
90
0.020
Why?
Ribosomal Protein S6
1
2012
18
0.020
Why?
Receptor, IGF Type 1
1
2013
64
0.020
Why?
Gene Frequency
1
2014
496
0.020
Why?
Gene-Environment Interaction
1
2014
190
0.020
Why?
Genes, p53
1
2012
56
0.020
Why?
Mortality
1
2015
375
0.020
Why?
Early Detection of Cancer
1
2018
506
0.020
Why?
Doxorubicin
1
2015
416
0.020
Why?
History, 21st Century
1
2013
224
0.020
Why?
Morbidity
1
2013
319
0.020
Why?
Washington
1
2013
157
0.020
Why?
Mutation, Missense
1
2014
334
0.020
Why?
History, 20th Century
1
2013
330
0.020
Why?
Population Surveillance
1
2015
481
0.020
Why?
Protein Binding
1
2018
2244
0.020
Why?
Tumor Burden
1
2013
326
0.020
Why?
Amino Acids
1
2015
515
0.020
Why?
Transcription, Genetic
1
2018
1432
0.020
Why?
Neovascularization, Pathologic
1
2013
287
0.020
Why?
Linear Models
1
2013
857
0.020
Why?
Anemia
1
2012
190
0.020
Why?
Feasibility Studies
1
2015
1135
0.020
Why?
Models, Statistical
1
2014
669
0.020
Why?
Leukocytes, Mononuclear
1
2012
585
0.020
Why?
Retrospective Studies
2
2022
17438
0.020
Why?
Prevalence
1
2016
2861
0.020
Why?
Machine Learning
1
2015
594
0.020
Why?
Radiotherapy, Adjuvant
1
2010
222
0.020
Why?
Socioeconomic Factors
1
2013
1327
0.020
Why?
DNA Methylation
1
2014
725
0.020
Why?
Neoplasms, Radiation-Induced
1
2009
100
0.020
Why?
Bone Marrow
1
2010
310
0.020
Why?
Age Distribution
1
2009
399
0.020
Why?
Sex Factors
1
2013
2107
0.020
Why?
Docosahexaenoic Acids
1
2008
91
0.020
Why?
Odds Ratio
1
2010
1077
0.020
Why?
Genome-Wide Association Study
1
2014
1537
0.020
Why?
Age of Onset
1
2009
558
0.020
Why?
Cell Differentiation
1
2014
1982
0.020
Why?
Registries
1
2015
2400
0.010
Why?
Social Support
1
2010
646
0.010
Why?
Survivors
1
2009
526
0.010
Why?
Patient Education as Topic
1
2010
770
0.010
Why?
Sensitivity and Specificity
1
2008
1998
0.010
Why?
Anxiety
1
2010
1125
0.010
Why?
Longitudinal Studies
1
2010
3017
0.010
Why?
Surveys and Questionnaires
1
2010
6073
0.010
Why?
Child
1
2015
22693
0.010
Why?
Ellis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)